Dr Reddy's Laboratories is currently trading at Rs. 1699.00, up by 19.00 points or 1.13% from its previous closing of Rs. 1680.00 on the BSE.
The scrip opened at Rs. 1680.00 and has touched a high and low of Rs. 1703.70 and Rs. 1680.00 respectively. So far 3216 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1728.70 on 02-Mar-2012 and a 52 week low of Rs. 1387.00 on 22-Aug-2011.
Last one week high and low of the scrip stood at Rs. 1703.70 and Rs. 1638.00 respectively. The current market cap of the company is Rs. 28741.33 crore.
The promoters holding in the company stood at 25.61% while Institutions and Non-Institutions held 40.92% and 16.02% respectively.
Dr Reddy's Laboratories, India’s second largest pharma company is likely to sign a definitive agreement with Japan-based Fujifilm by June 2012. This joint venture will develop and produce generic drugs for the Japanese market. It will take 2-3 years for the company to come out with products.
The company has to obtain product approvals from Japanese authorities before the launch. It had announced the partnership in July, 2011. As part of the JV agreement company is expected to set up a manufacturing facility. This JV will design products that fit the specific requirements of the Japanese market, aiming to deliver reliable, high quality generic drugs enabling the growth of generic drug market.
As per the agreement the new joint venture will have 51% stake owned by Fujifilm and 49% stake owned by Dr Reddy's. Making use of both Fujifilm's advanced quality control technologies and DRL's expertise in cost competitive production technologies for active pharmaceutical ingredients and formulations, the new company will develop, manufacture and promote competitive and high quality generic drugs.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1818.45 |
Dr. Reddys Lab | 1349.60 |
Cipla | 1482.05 |
Lupin | 2181.90 |
Zydus Lifesciences | 977.00 |
View more.. |